MUC1 and neoplasm: On the other hand, the internalisation of MUC1 specific antibodies by tumour cells allows other therapeutic approaches including the delivery of toxic compounds into the tumour cells, e.g. antibody drug conjugates or immunotoxins [90]–[92].